Search | The Pirbright Institute

Filters

Rinderpest destruction, what happens next?

In June 2019 The Pirbright Institute destroyed the last samples of rinderpest virus held in the World Reference Laboratory for rinderpest. This completed a major milestone in the World Organisation for Animal Health (OIE) and Food and Agriculture Organization of the United…

default publication image

Drivers of Crimean-Congo Hemorrhagic Fever in Natural Host and Effects of Control Measures, Bulgaria

Crimean-Congo hemorrhagic fever (CCHF) is an emerging tickborne disease and a World Health Organization priority. Although humans are accidental hosts, infection can lead to hemorrhagic fever with a high fatality rate. Domestic animals play a critical role in disease…

Flock of sheep in a line on a dry landscape

Study highlights factors driving Crimean-Congo haemorrhagic fever in livestock

A study has revealed crucial insights into the transmission patterns and risk factors of Crimean-Congo haemorrhagic fever virus (CCHFV) in sheep, a natural host of the virus. Led by The Pirbright Institute and based on sequential observational studies and a multi site…

Pirbright student wins award to study the role of insects in lumpy skin disease infection

First year PhD student Charlotte Cook was recently thrilled to learn that she is being given an In Vivo Skills Award from the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation. Only three such awards are offered by the BBSRC…

Two people stood in The Pirbriht Institute Plowright building atrium. They are looking at a notepad

Athena Swan at Pirbright

We are a proud holder of an Athena Swan Silver Award, demonstrating our commitment to progressing gender equality at the Institute.

default publication image

Rift Valley fever and invisible women

Public health interventions often neglect gender disparities. This perspective paper highlights the gendered risks using Rift Valley fever (RVF), a vector-borne zoonotic disease, as a case study, and discuss how gender inequality in RVF disease surveillance and control might…

Pirbright and GALVmed partner to develop safer Rift Valley fever vaccine

The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), has entered into a new agreement with GALVmed to develop and deploy a safer and more effective Rift Valley fever (RVF) vaccine for use in low- and middle-income countries…

pig lying in hay pirbright

Pigs can be used to test human flu vaccines say Pirbright scientists

A new study from researchers at The Pirbright Institute suggests that pigs may be a good model for evaluating the effectiveness of vaccines designed to protect against seasonal human flu. In a paper published in the journal Frontiers in Immunology the study, led by Dr Elma…

Photo of the front exterior of Pirbright's Jenner building. There are eight stone pillars. Blue sky with fluffy white clouds are see

Pirbright adviser receives Distinguished Veterinary Immunologist Award

A leading researcher dedicated to supporting the careers of future scientists has received the Distinguished Veterinary Immunologist Award from the 14th International Veterinary Immunology Symposium (IVIS2025). Professor Gary Entrican, who sits on The Pirbright Institute’s…

Pirbright receives Leader in Openness award

The Pirbright Institute is one of 13 organisations who have been announced as recipients of the first Leader in Openness awards from Understanding Animal Research (UAR). UAR Concordat Leader in Openness award Held for three years, 2019-22, the award recognises Pirbright’s…